{"count": 31, "results": [{"_id": "31953678", "pmid": 31953678, "title": "Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-beta signaling pathway.", "journal": "Hum Cell", "authors": ["Ma Z", "Zang W", "Wang H", "Wei X"], "date": "2020-04-01T00:00:00Z", "doi": "10.1007/s13577-019-00314-9", "meta_date_publication": "2020 Apr", "meta_volume": "33", "meta_issue": "2", "meta_pages": "330-336", "score": 50266.445, "text_hl": "Silibinin enhances anti-@<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@renal fibrosis@@@ effect of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@MK-521@@@ via downregulation of @GENE_TGFB1 @GENE_21803 @@@TGF-beta@@@ signaling pathway.", "citations": {"NLM": "Ma Z, Zang W, Wang H, Wei X. Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-beta signaling pathway. Hum Cell. 2020 Apr;33(2):330-336. PMID: 31953678", "BibTeX": "@article{31953678, title={Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-beta signaling pathway.}, author={Ma Z and Zang W and Wang H and Wei X}, journal={Hum Cell}, volume={33}, number={2}, pages={330-336}}"}}, {"_id": "40240316", "pmid": 40240316, "title": "Corrigendum to \"Anti-Fibrotic Effects of Lisinopril (ACE Inhibitor) and Fasudil (ROCK Inhibitor) in Combination for Canine Corneal Fibrosis In Vitro\".", "journal": "Vet Ophthalmol", "date": "2025-04-16T00:00:00Z", "doi": "10.1111/vop.70011", "meta_date_publication": "2025 Apr 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50262.105, "text_hl": "Corrigendum to \"Anti-Fibrotic Effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ (ACE Inhibitor) and @CHEMICAL_fasudil @CHEMICAL_MESH:C049347 @@@Fasudil@@@ (ROCK Inhibitor) in Combination for Canine @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@Corneal Fibrosis@@@ In Vitro\".", "citations": {"NLM": "Corrigendum to \"Anti-Fibrotic Effects of Lisinopril (ACE Inhibitor) and Fasudil (ROCK Inhibitor) in Combination for Canine Corneal Fibrosis In Vitro\". Vet Ophthalmol. 2025 Apr 16;():. PMID: 40240316", "BibTeX": "@article{40240316, title={Corrigendum to \"Anti-Fibrotic Effects of Lisinopril (ACE Inhibitor) and Fasudil (ROCK Inhibitor) in Combination for Canine Corneal Fibrosis In Vitro\".}, journal={Vet Ophthalmol}}"}}, {"_id": "39592228", "pmid": 39592228, "title": "Anti-fibrotic effects of lisinopril (ACE inhibitor) and fasudil (ROCK inhibitor) in combination for canine corneal fibrosis in vitro.", "journal": "Vet Ophthalmol", "authors": ["Routh BL", "Tripathi R", "Giuliano E", "Lujin P", "Sinha PR", "Mohan RR"], "date": "2024-11-26T00:00:00Z", "doi": "10.1111/vop.13304", "meta_date_publication": "2024 Nov 26", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50261.883, "text_hl": "Anti-fibrotic effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (ACE inhibitor) and @CHEMICAL_fasudil @CHEMICAL_MESH:C049347 @@@fasudil@@@ (ROCK inhibitor) in combination for @SPECIES_9615 @@@canine@@@ @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@corneal fibrosis@@@ in vitro.", "citations": {"NLM": "Routh BL, Tripathi R, Giuliano E, Lujin P, Sinha PR, Mohan RR. Anti-fibrotic effects of lisinopril (ACE inhibitor) and fasudil (ROCK inhibitor) in combination for canine corneal fibrosis in vitro. Vet Ophthalmol. 2024 Nov 26;():. PMID: 39592228", "BibTeX": "@article{39592228, title={Anti-fibrotic effects of lisinopril (ACE inhibitor) and fasudil (ROCK inhibitor) in combination for canine corneal fibrosis in vitro.}, author={Routh BL and Tripathi R and Giuliano E and Lujin P and Sinha PR and Mohan RR}, journal={Vet Ophthalmol}}"}}, {"_id": "35656292", "pmid": 35656292, "pmcid": "PMC9152216", "title": "Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line", "journal": "Front Pharmacol", "authors": ["Scisciola L", "Fontanella RA", "Surina", "Garofalo G", "Rizzo MR", "Paolisso G", "Barbieri M"], "date": "2022-05-17T00:00:00Z", "doi": "10.3389/fphar.2022.868365", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "868365", "score": 50259.625, "text_hl": "...Effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ treatment on proteins involved in @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@fibrosis@@@ and apoptosis. ", "citations": {"NLM": "Scisciola L, Fontanella RA, Surina, Garofalo G, Rizzo MR, Paolisso G, Barbieri M. Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line Front Pharmacol. 2022;13():868365. PMID: 35656292", "BibTeX": "@article{35656292, title={Potential Role of Lisinopril in Reducing Atherosclerotic Risk: Evidence of an Antioxidant Effect in Human Cardiomyocytes Cell Line}, author={Scisciola L and Fontanella RA and Surina and Garofalo G and Rizzo MR and Paolisso G and Barbieri M}, journal={Front Pharmacol}, volume={13}, pages={868365}}"}}, {"_id": "31550726", "pmid": 31550726, "title": "Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation.", "journal": "Nephron", "authors": ["Cortinovis M", "Aiello S", "Mister M", "Conde-Knape K", "Noris M", "Novelli R", "Solini S", "Rodriguez Ordonez PY", "Benigni A", "Remuzzi G"], "date": "2020-01-01T00:00:00Z", "doi": "10.1159/000502908", "meta_date_publication": "2020", "meta_volume": "144", "meta_issue": "1", "meta_pages": "38-48", "score": 50252.25, "text_hl": "Chronic treatment with ATXi or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ limited progressive @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@proteinuria@@@ and ameliorated @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@tubulointerstitial fibrosis@@@ compared with allograft @SPECIES_10116 @@@rats@@@, although the effects were more robust under ATX inhibition. ", "citations": {"NLM": "Cortinovis M, Aiello S, Mister M, Conde-Knape K, Noris M, Novelli R, Solini S, Rodriguez Ordonez PY, Benigni A, Remuzzi G. Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation. Nephron. 2020;144(1):38-48. PMID: 31550726", "BibTeX": "@article{31550726, title={Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation.}, author={Cortinovis M and Aiello S and Mister M and Conde-Knape K and Noris M and Novelli R and Solini S and Rodriguez Ordonez PY and Benigni A and Remuzzi G}, journal={Nephron}, volume={144}, number={1}, pages={38-48}}"}}, {"_id": "35767209", "pmid": 35767209, "title": "Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.", "journal": "Geroscience", "authors": ["Williams JM", "Murphy SR", "Wu W", "Border JJ", "Fan F", "Roman RJ"], "date": "2022-12-01T00:00:00Z", "doi": "10.1007/s11357-022-00610-7", "meta_date_publication": "2022 Dec", "meta_volume": "44", "meta_issue": "6", "meta_pages": "2845-2861", "score": 50249.22, "text_hl": "Administration of @CHEMICAL_empagliflozin @CHEMICAL_MESH:C570240 @@@empagliflozin@@@ alone or in combination with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ reduced @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@, @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@proteinuria@@@, @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@glomerular injury@@@, and @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@renal fibrosis@@@ in @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@STZ@@@-SS @SPECIES_10116 @@@rats@@@ without altering renal blood flow (RBF) or glomerular filtration rate (GFR). ", "citations": {"NLM": "Williams JM, Murphy SR, Wu W, Border JJ, Fan F, Roman RJ. Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension. Geroscience. 2022 Dec;44(6):2845-2861. PMID: 35767209", "BibTeX": "@article{35767209, title={Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.}, author={Williams JM and Murphy SR and Wu W and Border JJ and Fan F and Roman RJ}, journal={Geroscience}, volume={44}, number={6}, pages={2845-2861}}"}}, {"_id": "34144158", "pmid": 34144158, "title": "Clitoria ternatea L. extract prevents kidney damage by suppressing the Ang II/Nox4/oxidative stress cascade in l-NAME-induced hypertension model of rats.", "journal": "Ann Anat", "authors": ["Saengnak B", "Kanla P", "Samrid R", "Berkban T", "Mothong W", "Pakdeechote P", "Prachaney P"], "date": "2021-11-01T00:00:00Z", "doi": "10.1016/j.aanat.2021.151783", "meta_date_publication": "2021 Nov", "meta_volume": "238", "meta_issue": "", "meta_pages": "151783", "score": 50246.72, "text_hl": "Glomerular extracellular matrix accumulation, @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@renal fibrosis@@@, and increased serum @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@ levels were observed in @CHEMICAL_NG_Nitroarginine_Methyl_Ester @CHEMICAL_MESH:D019331 @@@l-NAME@@@-induced @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rats@@@ and attenuated by CT flower extract or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ co-treatment (p < 0.05). ", "citations": {"NLM": "Saengnak B, Kanla P, Samrid R, Berkban T, Mothong W, Pakdeechote P, Prachaney P. Clitoria ternatea L. extract prevents kidney damage by suppressing the Ang II/Nox4/oxidative stress cascade in l-NAME-induced hypertension model of rats. Ann Anat. 2021 Nov;238():151783. PMID: 34144158", "BibTeX": "@article{34144158, title={Clitoria ternatea L. extract prevents kidney damage by suppressing the Ang II/Nox4/oxidative stress cascade in l-NAME-induced hypertension model of rats.}, author={Saengnak B and Kanla P and Samrid R and Berkban T and Mothong W and Pakdeechote P and Prachaney P}, journal={Ann Anat}, volume={238}, pages={151783}}"}}, {"_id": "32684739", "pmid": 32684739, "pmcid": "PMC7336333", "title": "Medications in type-2 diabetics and their association with liver fibrosis", "journal": "World J Gastroenterol", "authors": ["Siddiqui MT", "Amin H", "Garg R", "Chadalavada P", "Al-Yaman W", "Lopez R", "Singh A"], "date": "2020-06-21T00:00:00Z", "doi": "10.3748/wjg.v26.i23.3249", "meta_date_publication": "2020 Jun 21", "meta_volume": "26", "meta_issue": "23", "meta_pages": "3249-3259", "score": 50244.484, "text_hl": "Medications associated with decreased risk of @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@AF@@@ included @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@, liraglutide, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ and @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ while the use of @CHEMICAL_Furosemide @CHEMICAL_MESH:D005665 @@@furosemide@@@ and @CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@ were associated with higher prevalence of @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@AF@@@.", "citations": {"NLM": "Siddiqui MT, Amin H, Garg R, Chadalavada P, Al-Yaman W, Lopez R, Singh A. Medications in type-2 diabetics and their association with liver fibrosis World J Gastroenterol. 2020 Jun 21;26(23):3249-3259. PMID: 32684739", "BibTeX": "@article{32684739, title={Medications in type-2 diabetics and their association with liver fibrosis}, author={Siddiqui MT and Amin H and Garg R and Chadalavada P and Al-Yaman W and Lopez R and Singh A}, journal={World J Gastroenterol}, volume={26}, number={23}, pages={3249-3259}}"}}, {"_id": "16458281", "pmid": 16458281, "title": "Lisinopril ameliorates paraquat-induced lung fibrosis.", "journal": "Clin Chim Acta", "authors": ["Mohammadi-Karakani A", "Ghazi-Khansari M", "Sotoudeh M"], "date": "2006-05-01T00:00:00Z", "doi": "10.1016/j.cca.2005.12.012", "meta_date_publication": "2006 May", "meta_volume": "367", "meta_issue": "1-2", "meta_pages": "170-4", "score": 50080.65, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ ameliorates @CHEMICAL_Paraquat @CHEMICAL_MESH:D010269 @@@paraquat@@@-induced @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@lung fibrosis@@@.", "citations": {"NLM": "Mohammadi-Karakani A, Ghazi-Khansari M, Sotoudeh M. Lisinopril ameliorates paraquat-induced lung fibrosis. Clin Chim Acta. 2006 May;367(1-2):170-4. PMID: 16458281", "BibTeX": "@article{16458281, title={Lisinopril ameliorates paraquat-induced lung fibrosis.}, author={Mohammadi-Karakani A and Ghazi-Khansari M and Sotoudeh M}, journal={Clin Chim Acta}, volume={367}, number={1-2}, pages={170-4}}"}}, {"_id": "11474692", "pmid": 11474692, "title": "Lisinopril shows regression of myocardial fibrosis in patients with hypertensive heart disease.", "journal": "Cardiovasc J S Afr", "date": "2001-02-01T00:00:00Z", "meta_date_publication": "2001 Feb-Mar", "meta_volume": "12", "meta_issue": "1", "meta_pages": "58", "score": 50071.08, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ shows regression of @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@myocardial fibrosis@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive heart disease@@@.", "citations": {"NLM": "Lisinopril shows regression of myocardial fibrosis in patients with hypertensive heart disease. Cardiovasc J S Afr. 2001 Feb-Mar;12(1):58. PMID: 11474692", "BibTeX": "@article{11474692, title={Lisinopril shows regression of myocardial fibrosis in patients with hypertensive heart disease.}, journal={Cardiovasc J S Afr}, volume={12}, number={1}, pages={58}}"}}]}